| PERIOD ENDING | 3-Jan-09 | 29-Dec-07 | 30-Dec-06 | | Total Revenue | 243,018 | 201,677 | 148,127 | | Cost of Revenue | 141,615 | 115,449 | 85,821 | | | Gross Profit | 101,403 | 86,228 | 62,306 | | | Operating Expenses | | Research Development | 2,486 | 2,389 | 2,262 | | Selling General and Administrative | 60,936 | 51,961 | 39,614 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 37,981 | 31,878 | 20,430 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 37,981 | 31,878 | 20,430 | | Interest Expense | 993 | 1,736 | 1,049 | | Income Before Tax | 36,988 | 30,142 | 19,381 | | Income Tax Expense | 11,215 | 8,821 | 6,509 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 25,773 | 21,321 | 12,872 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 25,773 | 21,321 | 12,872 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $25,773 | $21,321 | $12,872 |
|
0.34% Nasdaq 0.00%
Income Statement
